VN

Vikas Nenavath

Active Director Director DIN 10096181
DIN 10096181 First appointment May 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2023
Shareholding value •••• Premium profile

About Vikas Nenavath

Data last updated:

Vikas Nenavath is a Director at Delmarklife Sciences Private Limited (since 2023). Delmarklife Sciences Private Limited reported revenue of ₹5.9 Lakh (FY 2025).

DIN 10096181
Primary Designation Director
First Appointment 29 May 2023
Oldest Company Age 3 yrs
Largest company Delmarklife Sciences Private Limited · ₹5.9 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Delmarklife Sciences Private Limited U46497TS2023PTC173473
Director29 May 20232023₹5.9 Lakh (FY 2025)Active

Board colleagues of Vikas Nenavath

NameDINCompanyDesignation
Nenavath Padmavathi10096247Delmarklife Sciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Delmarklife Sciences Private Limited
Premium access

Shareholding and investment profile for Vikas Nenavath

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vikas Nenavath

Vikas Nenavath currently holds 1 directorship: Delmarklife Sciences Private Limited (Director, since 29 May 2023, revenue ₹5.9 Lakh (FY 2025)).

Vikas Nenavath was first appointed on 29 May 2023 as Director at Delmarklife Sciences Private Limited.

The current boards of Vikas Nenavath's companies include Nenavath Padmavathi (Delmarklife Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available